CGRP receptor antagonists
US9925178B2 · kind B2 · utility
4Cited by
21References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2017 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | May 5, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosures herein relate to novel compounds of formulawherein Ar1 and R1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.